Skip to content

Medical treatment of retained placenta: does it reduce the number of necessary surgical interventions? A randomised controlled trial in low resource setting

Treatment of a retained placenta with misoprostol, a double-blind randomised controlled trial in Tanzania

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16104753
Enrollment
117
Registered
2008-04-21
Start date
2008-04-04
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retained placenta Pregnancy and Childbirth Retained placenta and membranes

Interventions

Study medication will be randomised in blocks and the allocation of sealed envelopes will be in sequence of enrolment. Randomisation of misoprostol to placebo will be 2:1. 30 minutes after delivery of

Sponsors

Tanzanian German Programme to Support Health (TGPSH) (Tanzania)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women with a retained placenta 30 minutes after delivery of the newborn (and a pregnancy duration of at least 28 weeks [birth weight 1 kg]). All women will receive active management of third stage of labour before inclusion.

Exclusion criteria

Exclusion criteria: 1. Blood loss greater than 750 ml 30 minutes after delivery 2. Pulse rate greater than 120 beats/minute 3. Blood pressure (BP) dropped greater than 20 mmHg diastolic compared with BP before delivery 4. Anaemia (haemoglobin [Hb] less than 100 g/dl). Measurement of third trimester of pregnancy or around delivery

Design outcomes

Primary

MeasureTime frame
Reduction in the amount of manual removal of placenta (under anaesthesia) 60 minutes after delivery of the baby.

Secondary

MeasureTime frame
1. Blood loss 2. Need for blood transfusion Hb will be checked the morning after the manual removal or the sponteneous expulsion of the placenta. After this it will be decided if a blood transfusion is necessary.

Countries

Tanzania

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026